Search & Analyze

Jupiter Life Line Hospitals Ltd.

260.00−0.70 (−0.27%)

BSE · 30 Oct, 4:01 PM

: ₹8,402.29 Cr
: 45.07
: 4,155
: ₹260.00 - ₹254.05
: ₹337.90 - ₹230.41

Jupiter Life Line Hospitals Ltd. (JLHL) share price closed at ₹260.00 on the BSE on Friday, October 30, 2026, down by 0.27% from its of ₹260.70. In that session JLHL reached a of 260.00 and of 254.05. The for the session was 257.25. The stands at 271.64 and is at 270.49. Looking at , the stock ended the session moving sideways.

Stock Overview

₹258.20

₹260.70

₹257.25

₹271.64

Price 4.29% below

₹270.49

Price 3.88% below

Key Fundamentals

: 8,402.29 Cr₹8.40 Thousand Crore
: 5.69
: 45.07
: 5.15
: 49.73
: 398.12 Cr₹398.12 Crore
: 0.08 %
Sector
Industry: Hospital & Healthcare Services
: 13.39
: 0.33

Industry Comparison

Ratio	Company	Sector
	45.07	44.77
	0.33	0.20
	5.15	4.61
	3.02	1.81
	0.08 %	0.11 %
Operating Margin	22.76 %	19.15 %

Sector figures are the median of 154 listed Healthcare companies.

Peer Comparison

Name
APOLLO HOSP. APOLLOHOSP	8,400.00	57.80	1,20,779.11	0.24	610.40	38.41%	7,043.50	20.56%	21.73
MANIPALHOS MANIPALHOS	668.45	98.54	87,926.39	0.00	243.43	-4.18%	3,090.63	38.12%	13.93
MAXHEALTH MAXHEALTH	860.00	60.63	83,706.13	0.23	414.45	-15.64%	2,569.21	20.31%	14.97
ASTERDM ASTERDM	680.40	186.93	59,308.59	0.44	29.28	-68.70%	1,310.68	21.60%	16.22
FORTIS FORTIS	769.80	55.46	58,116.68	0.13	272.80	2.26%	2,545.03	17.46%	14.07
NH NH	1,700.00	43.06	34,741.34	0.26	301.15	16.50%	2,843.99	73.01%	16.20
MEDANTA MEDANTA	1,265.00	61.35	34,013.01	0.04	157.25	-1.09%	1,304.05	26.50%	19.38
Jupiter Life Line Hospitals Ltd. JLHL	260.00	45.07	8,402.29	0.08	56.36	-1.95%	456.50	15.97%	15.70

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
	200.56	221.29	228.39	242.30	243.22	263.18	272.61	291.38	288.58	335.05	332.81	336.66	352.95	393.63	365.37	387.84	410.98	456.50
Expenses	151.27	166.06	183.18	190.72	190.23	202.15	210.76	228.21	223.27	256.83	256.47	256.96	274.53	301.38	281.94	298.68	331.71	349.65
	49.29	55.23	45.22	51.58	53.00	61.03	61.85	63.17	65.31	78.22	76.34	79.70	78.42	92.25	83.43	89.16	79.27	106.85
	24.58%	24.96%	19.80%	21.29%	21.79%	23.19%	22.69%	21.68%	22.63%	23.34%	22.94%	23.67%	22.22%	23.44%	22.83%	22.99%	19.29%	23.41%
	1.99	2.54	2.40	1.28	3.65	3.20	7.91	10.34	6.91	7.41	7.21	6.88	12.82	11.27	2.73	10.66	10.59	10.54
Interest	10.01	10.08	11.24	10.94	12.16	12.23	1.03	0.93	1.08	1.16	2.82	5.61	8.27	7.84	7.55	9.01	12.86	13.83
	9.30	9.51	9.77	9.98	10.72	10.62	10.65	10.39	11.00	14.42	13.99	17.65	21.22	21.46	21.70	23.26	26.44	28.48
	31.98	38.17	26.61	31.95	33.76	41.37	58.08	62.20	60.14	70.04	66.73	63.32	61.75	74.22	56.91	67.56	50.55	75.08
	4.79%	29.05%	101.42%	50.70%	-59.94%	18.59%	24.82%	27.23%	25.84%	26.00%	21.76%	28.49%	28.83%	22.56%	25.32%	25.59%	25.80%	24.94%
	30.45	27.08	-0.38	15.75	54.00	33.68	43.67	45.05	44.47	51.65	52.09	45.18	43.89	57.35	42.55	50.21	37.49	56.17
	5.99	5.32	-0.07	2.79	9.55	5.14	6.66	6.87	6.78	7.88	7.94	6.89	6.69	8.75	6.49	7.66	5.72	1.71

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME:
Operating Income	733.12	892.54	1,073.44	1,302.40	1,499.79
Operating Income (Net)	733.12	892.54	1,073.44	1,302.40	1,499.79
EXPENDITURE :
Increase/Decrease in Stock	-2.31	-3.68	-2.34	-2.69	-11.88
Cost of Medicines and Consumables	144.54	160.86	191.81	258.17	299.14
Power & Fuel Cost	13.77	20.86	21.40	25.22	25.58
Employee Cost	128.98	151.50	189.94	225.24	256.33
Hospital Operation Expenses	62.37	80.55	91.84	121.69	147.07
Selling, Administration and Other Expenses	216.73	278.57	313.25	354.64	428.16
Miscellaneous Expenses	15.67	2.56	25.45	20.02	13.98
	579.74	691.22	831.34	1,002.28	1,158.39
Operating Profit (Excl OI)	153.39	201.32	242.09	300.12	341.40
	4.02	10.42	22.05	28.35	44.23
	157.41	211.74	264.14	328.47	385.63
Interest	43.94	42.27	26.34	10.71	32.66
PBDT	113.47	169.47	237.80	317.76	352.96
	36.16	38.56	42.38	57.08	87.64
Profit Before Taxation & Exceptional Items	77.32	130.91	195.42	260.68	265.32
Exceptional Income / Expenses	-0.20	-2.20			-4.89
	77.12	128.71	195.42	260.68	260.44
Provision for Tax	25.99	55.80	18.80	66.92	66.25
	51.13	72.91	176.61	193.75	194.19
Extra items	0.00	0.00	0.00	0.00	0.00
Minority Interest				-0.55	-0.18
Other Consolidated Items			1.24
Consolidated Net Profit	51.13	72.91	177.85	193.20	194.01
Adjustments to PAT			-1.48
Profit Balance B/F	156.24	200.56	228.00	401.14	566.16
Appropriations	207.36	273.46	404.38	594.34	760.17
Equity Dividend %	10.00%	10.00%	10.00%	10.00%	10.00%
	10.05	12.90	27.13	29.47	29.59
Adjusted EPS	2.01	2.58	5.43	5.89	5.92

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	50.87	56.52	65.57	65.57	65.57
Share Warrants & Outstandings	1.79
Total Reserves	240.90	309.17	1,103.47	1,290.68	1,478.52
Reserve excluding Revaluation Reserve	240.90	309.17	1,103.47	1,290.68	1,478.52
Revaluation reserve	0.00	0.00
	293.55	365.69	1,169.04	1,356.24	1,544.08
Minority Interest	-5.12	-1.78	-0.30	0.06	0.01
Secured Loans	463.27	452.51		321.75	500.90
Unsecured Loans	1.25
Deferred Tax Assets / Liabilities	32.54	36.98	3.75	7.12	9.74
Other Long Term Liabilities				62.34	65.53
Long Term Provisions			3.10	11.22	16.46
Total Non-Current Liabilities	497.06	489.49	6.84	402.43	592.63
Trade Payables	61.11	70.73	62.24	69.10	95.54
Other Current Liabilities	19.05	29.43	22.69	83.06	118.42
Short Term Borrowings	23.07	4.73		0.71
Short Term Provisions	19.97	27.25	20.82	5.52	12.61
Total Current Liabilities	123.20	132.14	105.75	158.39	226.58
Total Liabilities	908.70	985.53	1,281.33	1,917.12	2,363.30
Gross Block	891.24	965.10	1,005.29	1,290.16	1,781.08
Less: Accumulated Depreciation	207.33	245.40	287.66	312.16	397.20
	683.92	719.70	717.63	978.00	1,383.88
	26.62	29.15	74.00	185.11	129.21
Non Current Investments	0.15	0.15	0.14	0.12	0.10
Long Term Investment	0.15	0.15	0.14	0.12	0.10
Long Term Loans & Advances	10.78	6.70	57.89	54.69	154.82
Other Non Current Assets	6.80	20.58	21.90	6.66	10.39
Total Non-Current Assets	728.26	776.27	871.57	1,224.58	1,678.40
Currents Investments	2.73	1.40	16.87	507.10	485.70
Inventories	15.36	19.00	21.34	26.46	38.34
Sundry Debtors	27.87	45.69	57.21	43.23	75.54
Cash and Bank	103.37	134.46	301.25	94.98	58.17
Other Current Assets	2.75	4.91	5.78	13.37	17.85
Short Term Loans and Advances	28.37	3.80	7.32	7.39	9.30
Total Current Assets	180.44	209.26	409.77	692.54	684.90
Net Current Assets (Including Current Investments)	57.24	77.12	304.01	534.15	458.33
Total Assets	908.70	985.53	1,281.33	1,917.12	2,363.30
	1.43	5.04	5.04	4.93	4.93
Total Debt	495.25	468.63	0.00	325.71	508.53
	57.36	64.70	178.30	206.85	235.50
Adjusted Book Value	57.36	64.70	178.30	206.85	235.50

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	77.12	128.71	195.42	260.68	265.32
Adjustment	77.08	76.00	49.70	49.25	87.68
Changes In working Capital	-8.60	-54.25	-80.91	21.01	-21.43
Cash Flow after changes in Working Capital	145.60	150.47	164.20	330.94	331.57
Cash Flow from Operating Activities	136.97	117.17	114.52	266.74	267.71
Cash Flow from Investing Activities	-85.25	-103.57	-246.14	-497.33	-441.93
Cash Flow from Financing Activitie	33.18	17.50	128.16	296.71	136.47
Net Cash Inflow / Outflow	84.90	31.10	-3.47	66.11	-37.76
Opening Cash & Cash Equivalents	18.46	103.37	26.48	26.40	92.52
Closing Cash & Cash Equivalent	103.37	134.46	23.01	92.52	54.76

Ratios

Valuation

45.07

5.15

22.47

5.18

5.69

49.73

Profitability

13.39

15.70

9.07

22.76

12.95

Leverage & Liquidity

0.33

3.02

8.97

Returns

0.08

0.70

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26	Sep '26
	40.91	40.91	40.91	40.91	40.91	40.91	40.91	40.91	40.91	40.91
	19.91	22.29	22.37	22.25	22.17	22.60	22.49	22.07	22.47	24.84
	39.17	36.79	36.72	36.84	36.92	36.50	36.59	37.02	36.62	34.25
	59.09	59.09	59.09	59.09	59.09	59.09	59.09	59.09	59.09	59.09
No. of Shareholders	35,797	34,081	33,914	33,956	34,192	34,361	33,620	32,985	33,194	33,255

Mutual Funds Invested(30)

Based on each fund's latest monthly portfolio · Sep 2026

A total of 26 active funds hold 13.45% in Jupiter Life Line Hospitals Ltd., contributing to ₹1.12K Cr of holdings

Fund				As of
SB SBI Multicap Fund - Growth - Direct PlanMulti Cap Fund	490.79	2.09	1,93,53,082	Sep '26
SB SBI Healthcare Opportunities Fund - Growth - Direct PlanPharma & Health Care	126.80	2.16	50,00,000	Sep '26
HD HDFC Multi Cap Fund - Growth - Direct PlanMulti Cap Fund	107.92	0.55	42,55,577	Sep '26
HD HDFC Small Cap Fund - Growth - Direct PlanSmall cap Fund	107.73	0.26	42,47,850	Sep '26
HD HDFC Pharma and Healthcare Fund - Growth - Direct PlanPharma & Health Care	58.95	1.68	23,24,391	Sep '26
AB Aditya Birla Sun Life Multi-Cap Fund - Growth - Direct PlanMulti Cap Fund	48.75	0.67	19,22,125	Sep '26
UT UTI Healthcare Fund - Growth - Direct PlanPharma & Health Care	29.84	2.09	11,76,815	Sep '26
IP ICICI Prudential Small Cap Fund - Growth - Direct PlanSmall cap Fund	20.02	0.20	7,89,385	Sep '26
UT UTI Small Cap Fund - Growth - Direct PlanSmall cap Fund	18.60	0.36	7,33,345	Sep '26
AB Aditya Birla Sun Life Pharma & Healthcare Fund - Growth - Direct PlanPharma & Health Care	16.66	1.55	6,57,040	Sep '26

Corporate Actions

Showing: All

Date	Type	Details	Ex-Date	Record Date
2026-10-08	Board Meeting	Quarterly Results
2026-07-27	Board Meeting	Quarterly Results
2026-07-20	Stock Split Or Consolidation of Shares	Stock Split from Rs.10/- to Rs.2	2026-07-23	2026-07-24

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

HealthcareHospital & Healthcare Services

Jupiter Life Line Hospitals Ltd. operates in the Healthcare sector under the Hospital & Healthcare Services industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

9 members across the board and senior leadership

Ajay Thakker

Chairman & Managing Director

₹4.20 Cr

Mar '26

Ankit Thakker

Managing Director & CEO

₹3.90 Cr

Mar '26

Vadapatra Raghavan

Non Executive Director

—

Darshan Vora